TABLE 1.
Dose | (mg/kg) | Oral | Intravenous | |||
---|---|---|---|---|---|---|
10 | 30 | 10 | 30 | |||
ICR | C max | (ng/mL) | 5417 | 17 367 | — | — |
C 0.5 h | (ng/mL) | — | — | 15 133 | 47 067 | |
T max | (h) | 2.00 | 2.00 | — | — | |
AUC0‐last | (h·ng/mL) | 40 124 | 164 672 | 98 842 | 498 982 | |
CLtot | (mL/h/kg) | — | — | 100 | 59.8 | |
V d,ss | (mL/kg) | — | — | 475 | 337 | |
t 1/2 | (h) | 3.96 | 3.64 | 3.74 | 3.11 | |
PXB | C max | (ng/mL) | 1277 | 4180 | — | — |
C 0.5 h | (ng/mL) | — | — | 1840 | 5903 | |
T max | (h) | 2.33 | 0.83 | — | — | |
AUC0‐last | (h·ng/mL) | 6593 | 25 898 | 7989 | 24 388 | |
CLtot | (mL/h/kg) | — | — | 1169 | 1161 | |
V d,ss | (mL/kg) | — | — | 2432 | 3404 | |
t 1/2 | (h) | 5.26 | 6.71 | 1.30 | 2.22 |
Abbreviations: AUC0‐last, AUC from time zero to 8 h (intravenous administration in PXB mice) and time zero to 24 h (others); —, not applicable.